Interventional Treatment for Hepatic Artery Thrombosis after Liver Transplantation
Hua Zhang,Sheng Qian,Rong Liu,Wei Yuan,Jian-Hua Wang
DOI: https://doi.org/10.1016/j.jvir.2017.04.026
IF: 3.682
2017-01-01
Journal of Vascular and Interventional Radiology
Abstract:Purpose: To evaluate short-term and long-term effectiveness of interventional treatment for hepatic artery thrombosis (HAT).Materials and Methods: From March 2003 to October 2015, 34 patients (32 male and 2 female; mean age, 45 y; range 7-64 y) with HAT were identified 0-21d (mean 6.5 d +/- 6.0) after liver transplantation and underwent interventional treatments. Technical success, clinical success, complications, hepatic artery patency, and survival time were assessed.Results: All 34 patients underwent urokinase thrombolytic treatment. The mean dosage of urokinase was 1,250,000 U +/- 1,000,000 (range, 350,000-9,000,000 U). Thrombolysis treatment required 5-120 h (mean 50 h +/- 31) for completion. In 21 patients, stents were also implanted during thrombolytic treatment. In 3 patients with splenic artery steal syndrome, proximal splenic artery embolization was performed during thrombolytic treatment. The technical and clinical success rate was 91% (31/34), with treatment failure in 3 children. Hemorrhage was observed in 11 cases. Local necrotic foci in the transplanted liver were found on CT in 5 patients. Complications associated with the interventional procedures occurred in 2 patients. Patency rates of the hepatic artery at 1 y, 2 y, 3 y, and 5 y were 96%, 93%, 83%, and 83%. Overall survival rate at 1 y, 2 y, 3 y, and 5 y were 82%, 73%, 57%, and 57%.Conclusions: Interventional treatment can achieve satisfactory short-term and long-term effectiveness for adult HAT.